Skip to main content

Advertisement

Log in

Protective effects of berberine as a natural antioxidant and anti-inflammatory agent against nephrotoxicity induced by cyclophosphamide in mice

  • Original Article
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Abstract

Purpose

Cyclophosphamide is an alkylating agent with nephrotoxicity that constrains its clinical application. Berberine is an isoquinoline derivative alkaloid with biological functions like antioxidant and anti-inflammatory. The current research intended to examine the nephroprotective impacts of berberine against cyclophosphamide-stimulated nephrotoxicity.

Methods

Forty animal subjects were randomly separated into five categories of control (Group I), cyclophosphamide (200 mg/kg, i.p., on 7th day) (Group II), and groups III and IV that received berberine 50 and 100 mg/kg orally for seven days and a single injection of cyclophosphamide on 7th day. Group V as berberine (100 mg/kg, alone). On day 8, blood samples were drawn from the retro-orbital sinus to determine serum levels of blood urea nitrogen (BUN), creatinine (Cr), neutrophil gelatinase-associated lipocalin (NGAL), and kidney injury molecule-1 (KIM-1) as biomarkers for kidney injury. Nitric oxide (NO), malondialdehyde (MDA) and glutathione (GSH) levels, catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GPx) activities as oxidative stress factors, tumor necrosis factor-α (TNF-α) and interleukin 1 beta (IL-1β) levels as inflammatory mediators were assessed in kidney tissue.

Results

The results of this study demonstrated that berberine was able to protect remarkably the kidney from CP-induced injury through decreasing the level of BUN, Cr, NGAL, KIM-1, NO, MDA TNF-α, IL-1β and increasing the level of GSH, CAT, SOD, and GPx activities.

Conclusion

Berberine may be employed as a natural agent to prevent cyclophosphamide-induced nephrotoxicity through anti-oxidant and anti-inflammatory effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Availability of data and materials

All data generated or analyzed during this study are included in this published article [and its supplementary information files].

References

  • Aebi H (1984) [13] Catalase in vitro. Methods Enzymol 105:121–126

    Article  CAS  Google Scholar 

  • Bradford N (1976) A rapid and sensitive method for the quantitation microgram quantities of a protein isolated from red cell membranes. Anal Biochem 72:e254

    Article  Google Scholar 

  • Chen X, Zhang Y, Zhu Z, Liu H, Guo H, Xiong C, Xie K, Zhang X, Su S (2016) Protective effect of berberine on doxorubicin-induced acute hepatorenal toxicity in rats. Mol Med Rep 13:3953–3960

    Article  CAS  Google Scholar 

  • Crivellari D, Bonetti M, Castiglione-Gertsch M, Gelber RD, Rudenstam C-M, Thürlimann B, Price KN, Coates AS, Hürny C, Bernhard J (2000) Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII. J Clin Oncol 18:1412–1422

    Article  CAS  Google Scholar 

  • Edelstein CL (2017) Biomarkers in acute kidney injury. Biomarkers of Kidney Disease 241–315

  • El-Naggar SA, Alm-Eldeen AA, Germoush MO, El-Boray KF, Elgebaly HA (2015) Ameliorative effect of propolis against cyclophosphamide-induced toxicity in mice. Pharm Biol 53:235–241

    Article  CAS  Google Scholar 

  • Fraiser LH, Kanekal S, Kehrer JP (1991) Cyclophosphamide toxicity. Drugs 42:781–795

    Article  CAS  Google Scholar 

  • Goudarzi M, Khodayar MJ, Hosseini Tabatabaei SMT, Ghaznavi H, Fatemi I, Mehrzadi S (2017) Pretreatment with melatonin protects against cyclophosphamide-induced oxidative stress and renal damage in mice. Fundam Clin Pharmacol 31:625–635

    CAS  PubMed  Google Scholar 

  • Goudarzi M, Kalantar M, Sadeghi E, Karamallah MH, Kalantar H (2021) Protective effects of apigenin on altered lipid peroxidation, inflammation, and antioxidant factors in methotrexate-induced hepatotoxicity. Naunyn Schmiedebergs Arch Pharmacol 394:523–531

    Article  CAS  Google Scholar 

  • Goudarzi M, Esmaeilizadeh M, Dolatshahi M, Kalantar H, Frouzandeh H, Kalantar M (2018) Protective effect of elaeagnus angustifolia L. Fruit hydroalcoholic extract on cyclophosphamide-induced nephrotoxicity in mice. Shiraz E Med J 19

  • Goudarzi M, Karamallah MH, Malayeri A, Kalantar M, Mansouri E, Kalantar H (2020) Protective effect of alpha-lipoic acid on di-(2-ethylhexyl) phthalate-induced testicular toxicity in mice. Environ Sci Pollut Res 1–9

  • Halliwell B (2001) Free radicals and other reactive species in disease. e LS

  • Hamsa T, Kuttan G (2011) Protective role of Ipomoea obscura (L.) on cyclophosphamide-induced uro-and nephrotoxicities by modulating antioxidant status and pro-inflammatory cytokine levels. Inflammopharmacology 19:155–167

    Article  CAS  Google Scholar 

  • Hasanein P, Ghafari-Vahed M, Khodadadi I (2017) Effects of isoquinoline alkaloid berberine on lipid peroxidation, antioxidant defense system, and liver damage induced by lead acetate in rats. Redox Rep 22:42–50

    Article  CAS  Google Scholar 

  • Hoitsma AJ, Wetzels JF, Koene RA (1991) Drug-induced nephrotoxicity. Drug Safety 6:131–147

    Article  CAS  Google Scholar 

  • Kalantar M, Houshmand G, Kalantar H, Asadi M, Goudarzi M (2016b) Protective effect of hydroalcoholic extract of Lavandula officinalis L. on gentamicin induced nephrotoxicity in rats. J Babol Univ Med Sci 18:62–67

    Google Scholar 

  • Kalantar H, Sabetkasaei M, Shahriari A, Haj Molla Hoseini M, Mansouri S, Kalantar M, Kalantari A, Khazaei Poul Y, Labibi F, Moini-Zanjani T (2016a) The effect of rapamycin on oxidative stress in MCF-7 and MDA MB-231 human breast cancer cell lines. Jundishapur J Nat Pharm Prod 11

  • Kuo C-L, Chi C-W, Liu T-Y (2004) The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett 203:127–137

    Article  CAS  Google Scholar 

  • Lawson M, Vasilaras A, De Vries A, Mactaggart P, Nicol D (2008) Urological implications of cyclophosphamide and ifosfamide. Scand J Urol Nephrol 42:309–317

    Article  CAS  Google Scholar 

  • Li Z, Geng Y-N, Jiang J-D, Kong W-J (2014) Antioxidant and anti-inflammatory activities of berberine in the treatment of diabetes mellitus. Evid-Based Complement Alternat Med 2014

  • Lou T, Zhang Z, Xi Z, Liu K, Li L, Liu B, Huang F (2011) Berberine inhibits inflammatory response and ameliorates insulin resistance in hepatocytes. Inflammation 34:659–667

    Article  CAS  Google Scholar 

  • Mahmoud AM, Abdel-Rahman MM, Bastawy NA, Eissa HM (2017) Modulatory effect of berberine on adipose tissue PPARγ, adipocytokines and oxidative stress in high fat diet/streptozotocin-induced diabetic rats. J Appl Pharm Sci 7:1–10

    Google Scholar 

  • Moore K, Roberts LJ (1998) Measurement of lipid peroxidation. Free Radical Res 28:659–671

    Article  CAS  Google Scholar 

  • Najafi H, Ashtiyani SC, Sayedzadeh SA (2015) Therapeutic effects of curcumin on the functional disturbances and oxidative stress induced by renal ischemia/reperfusion in rats. Avicenna J Phytomed 5:576

    CAS  PubMed  PubMed Central  Google Scholar 

  • Neurath MF (2014) Cytokines in inflammatory bowel disease. Nat Rev Immunol 14:329–342

    Article  CAS  Google Scholar 

  • Oktem G, Uysal A, Oral O, Sezer ED, Olukman M, Erol A, Akgur SA, Bilir A (2012) Resveratrol attenuates doxorubicin-induced cellular damage by modulating nitric oxide and apoptosis. Exp Toxicol Pathol 64:471–479

    Article  CAS  Google Scholar 

  • Perini P, Calabrese M, Rinaldi L, Gallo P (2007) The safety profile of cyclophosphamide in multiple sclerosis therapy. Expert Opin Drug Saf 6:183–190

    Article  CAS  Google Scholar 

  • Riddles PW, Blakeley RL, Zerner B (1979) Ellman’s reagent: 5, 5′-dithiobis (2-nitrobenzoic acid)—a reexamination. Anal Biochem 94:75–81

    Article  CAS  Google Scholar 

  • Rodriguez-Antona C, Ingelman-Sundberg M (2006) Cytochrome P 450 pharmacogenetics and cancer. Oncogene 25:1679–1691

    Article  CAS  Google Scholar 

  • Salazar JH (2014) Overview of urea and creatinine. Lab Med 45:e19–e20

    Article  Google Scholar 

  • Stankiewicz A, Skrzydlewska E, Makiela M (2002) Effects of amifostine on liver oxidative stress caused by cyclophosphamide administration to rats. Drug Metab Drug Interact 19:67–82

    Article  CAS  Google Scholar 

  • Sun Y, Xun K, Wang Y, Chen X (2009) A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs. Anticancer Drugs 20:757–769

    Article  CAS  Google Scholar 

  • Temel Y, Kucukler S, Yıldırım S, Caglayan C, Kandemir FM (2020) Protective effect of chrysin on cyclophosphamide-induced hepatotoxicity and nephrotoxicity via the inhibition of oxidative stress, inflammation, and apoptosis. Naunyn Schmiedebergs Arch Pharmacol 393:325–337

    Article  CAS  Google Scholar 

  • Wadie W, Mohamed AH, Masoud MA, Rizk HA, Sayed HM (2021) Protective impact of lycopene on ethinylestradiol-induced cholestasis in rats. Naunyn Schmiedebergs Arch Pharmacol 394:447–455

    Article  CAS  Google Scholar 

  • Wahlang B, Falkner KC, Cave MC, Prough RA (2015) Role of cytochrome P450 monooxygenase in carcinogen and chemotherapeutic drug metabolism. Adv Pharmacol 74:1–33

    Article  CAS  Google Scholar 

  • Wang X, Feng S, Ding N, He Y, Li C, Li M, Ding X, Ding H, Li J, Wu J (2018) Anti-inflammatory effects of berberine hydrochloride in an LPS-induced murine model of mastitis. Evid-Based Complement Alternat Med 2018

  • Yu X, Wang Y, Dai F, Zhao J, Li P (2019) The protective effects of Berberine and Hesperidin on inflammatory factor-stimulating cardiac fibroblasts. Eur Rev Med Pharmacol Sci 23:5468–5476

    PubMed  Google Scholar 

  • Zhang S, Zhang B, Dai W, Zhang X (2011) Oxidative damage and antioxidant responses in Microcystis aeruginosa exposed to the allelochemical berberine isolated from golden thread. J Plant Physiol 168:639–643

    Article  CAS  Google Scholar 

  • Zhang X, He H, Liang D, Jiang Y, Liang W, Chi Z-H, Ma J (2016a) Protective effects of berberine on renal injury in streptozotocin (STZ)-induced diabetic mice. Int J Mol Sci 17:1327

    Article  Google Scholar 

  • Zhang Z, Li X, Li F, An L (2016b) Berberine alleviates postoperative cognitive dysfunction by suppressing neuroinflammation in aged mice. Int Immunopharmacol 38:426–433

    Article  CAS  Google Scholar 

  • Zhou J-Y, Zhou S-W (2011) Protective effect of berberine on antioxidant enzymes and positive transcription elongation factor b expression in diabetic rat liver. Fitoterapia 82:184–189

    Article  CAS  Google Scholar 

Download references

Funding

This work was supported by Deputy of Research of Shoushtar University of Medical Sciences, Shoushtar, Iran (Grant number: TRC-9803) and Vice-Chancellor of Research, Toxicology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Author information

Authors and Affiliations

Authors

Contributions

MK and MAM conceived and designed the study. MAM, HK, and ES performed experiments. MAM, MG, and ES analyzed data. HK and HRK wrote the manuscript. All authors read and approved the manuscript and all data were generated in-house and that no paper mill was used.

Corresponding author

Correspondence to Mojtaba Kalantar.

Ethics declarations

Ethics approval

The investigation complies with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication no. 85–23, revised 1996). The investigation complies with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication no. 85–23, revised 1996). The Animal Ethics Committee of the Ahvaz Jundishapur University of Medical Sciences approved our research protocol (Ethic code: IR.BHN.REC.1397.033).

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PZF 2833 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mombeini, M.A., Kalantar, H., Sadeghi, E. et al. Protective effects of berberine as a natural antioxidant and anti-inflammatory agent against nephrotoxicity induced by cyclophosphamide in mice. Naunyn-Schmiedeberg's Arch Pharmacol 395, 187–194 (2022). https://doi.org/10.1007/s00210-021-02182-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00210-021-02182-3

Keywords

Navigation